Centers | Texas Venture Labs

Spectraphase

SpectraPhase proposes to develop, patent and commercialize technology for a blood glucose monitor that takes continuous readings on a real-time basis. With superior diagnostic data, hospital ICU staff can properly manage patients' blood sugar levels and expect both better patient outcomes and significant cost reductions for ICU administrators. 

SpectraPhase is led by CEO Chris Condit, a graduate student at UT, and founding member of CardioSpectra, an Austin-based medical diagnostics startup that successfully sold for $63M in 2007.  

Page last updated: 9/3/2013